Searchable abstracts of presentations at key conferences in endocrinology

ea0054is2 | (1) | NuclearReceptors2018

Androgen and estrogen receptors in breast tissues: opponents or teammates?

Hickey Theresa E

The balance of androgen and estrogen hormone activity determines the degree of breast development in males and females. A predominance of androgen action impedes whereas a predominance of estrogen action promotes breast development. This sex hormone antagonism is mechanistically mediated by androgen and estrogen receptors (AR, ER). The alpha form of ER (ERα) is required for normal breast development and is the driving oncogene in the majority of breast cancers. The AR is ...

ea0054is4 | (1) | NuclearReceptors2018

Estrogen receptor cistromics in breast tumors: from biomarkers to novel drug targets

Flach Koen Dorus , Periyasamy Manikandan , Jadhav Ajit , Hickey Theresa E , Opdam Mark , Patel Hetal , Canisius Sander , Wilson David M , Dorjsuren Dorjbal , Nieuwland Marja , Kluin Roel , Zakharov Alexey V , Wesseling Jelle , Wessels Lodewyk Frederik Ary , Linn Sabine Charlotte , Tilley Wayne D , Simeonov Anton , Ali Simak , Zwart Wilbert

Estrogen receptor α (ERα) is a key transcriptional regulator in the majority of breast cancers. ERα-positive patients are frequently treated with tamoxifen, but resistance is common. Through ChIP-seq analyses, we presviously identified direct target genes of ERα acting in complex with SRC1, SRC2 or SRC3 (Zwart et al., 2011 EMBO J). Only the 111 genes there were under direct control of ERα in conjunction with SRC3 (but not the other two p160s) predicted...